0001490953-24-000001.txt : 20240315 0001490953-24-000001.hdr.sgml : 20240315 20240315143419 ACCESSION NUMBER: 0001490953-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 504(b)(1) (not (i), (ii) or (iii)) ITEM INFORMATION: 06b FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 EFFECTIVENESS DATE: 20240315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunophotonics, Inc. CENTRAL INDEX KEY: 0001490953 ORGANIZATION NAME: IRS NUMBER: 264471225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507751 FILM NUMBER: 24754041 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE, #303 (BAL) CITY: ST. LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 636-675-6161 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE, #303 (BAL) CITY: ST. LOUIS STATE: MO ZIP: 63108 FORMER COMPANY: FORMER CONFORMED NAME: ImmunoPhotonics, Inc. DATE OF NAME CHANGE: 20100503 D 1 primary_doc.xml X0708 D LIVE 0001490953 Immunophotonics, Inc. 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 314-501-1919 DELAWARE ImmunoPhotonics, Inc. Corporation true Luciano Alleruzzo 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Executive Officer Director Promoter Tomas Hode 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Executive Officer Director Promoter Bobby W. Sandage 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Director Wei R. Chen 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Director Promoter Charlie Bolten 4340 Duncan Ave., Suite 212 St. Louis, MO 63110 St. Louis MO MISSOURI 63110 Director Jonathan Knowles 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Director Miguel Zubizarreta 4340 Duncan Ave. Suite 212 St. Louis MO MISSOURI 63110 Director Pharmaceuticals Decline to Disclose 04 06b false 2024-02-29 false true false 25000 4000000 1516746 2483254 Rolling closings ongoing as of date of filing. false 17 0 0 0 A portion of the gross proceeds will be used for general working capital, which may include salary payments to executive officers. An estimate of such amount is unknown at this time. false Immunophotonics, Inc. /s/ Alexander Hurst Alexander Hurst Corporate Secretary, General Counsel, and VP of Operations 2024-03-15